American Biomanufacturing Summit
Lunch & Learn
Roundtables
TABLE 1
Simon Trigg
Senior Director, Supply Chain
Rentschler BioPharma Inc.
How is AI being embedded into your daily Supply Chain decision‑making and operations?
Spots Remaining: 0
Chidi Obi
Abcuro
Hirak Desai
Navigator Medicines
Jin Li
BeOne Medicines
Krishnaveni Gottam
Genetix Biotherapeutics
Michael Suarez
GSK
Padraig Gavin
N/A
Polly Mak
Kardigan
Rene Sielmann
Bayer
Yunzhi Xiao
89bio
TABLE 2
Michael Dunn
Chief Commerical Officer
Afton Scientific
Flexible Aseptic Fill‑Finish for Biologics & Small Molecules
Spots Remaining: 0
Cherie Ali
Alector, Inc.
Christopher Brown
Seattle Children's Therapeutics
Courtney Wood
SteriMax Inc.
Diane Yu
Electra Therapeutics
Ekta Mahajan
Gilead
Janice Salmon
BMS
Michael Wong
Nkarta
Ming Aquila
Ionis 6
Purbasa Patnaik
Exelixis
TABLE 3
Ross Turmell
Principal Scientist
Cytiva
Open Discussion: Reducing/Removing PUPSIT Requirements from Annex 1
Spots Remaining: 0
Ellen Huynh
Nkarta Inc.
Jose Caraballo
Kite
Mike Ong
Candid Therapeutics
Niraj Ramachandran
Genentech
Siegfried Hackl
Ultragenyx Inc..
Stephanie Le
Nkarta
Suri Monsef
BeOne medicines
Thomas Ridel
SANOFI
Zarna Patel
Abcuro. Inc,
TABLE 4
Gord Adamson, Ph.D.
Senior Directory of Technical Operations
Resilience
Accelerating Therapies to the Clinic While Assuring Commercial Success – Is There a Solution?
Spots Remaining: 0
Beatrice Smith
Keck Graduate Institute
Callum Chapman
AstraZeneca
Guido Palermo
Atara Biotherapeutics, Inc.
Lawhan Blackett
Astrazeneca
Monica Kukreja
ArsenalBio
Saurin Patel
Takeda Pharmaceuticals
Stephanie Hawthorne
Bristol Myers Squibb
Suzann Muy
Bayer
Wendy Larson
Astellas Gene Therapies
TABLE 5
Joe Petrosky
SVP, Global Sales
PBS Biotech Inc
Cell Therapy from Start to Scale: How to Stay on the Leading Edge without Ending Up on the Bleeding Edge
Spots Remaining: 0
Allen Henderson
Sutro Biopharma
Amy Giunta
Moderna
Athena Wong
Sana Biotechnology
Deep Shah
Sana Biotechnology
Edmond Ma
Boehringer Ingelheim
Purba Dain
Kite Pharma
Rajat Saggar
Vericel
Vikash Sharma
AstraZeneca
Zhuojin Xu
Allogene Therapeutics
TABLE 6
Sven Lee
SVP, Global Business Development
Bionova Scientific
Process by Design: De-Risking CMC Pathways from Development to GMP
Spots Remaining: 0
Alexis Chen
AstraZeneca
Angelina Johonnot
Johnson and Johnson
Anthony Wong
Nkarta
Anubhav Arora
Apellis Pharmaceuticals
Megumi Noguchi
Electra Therapeutics
Ranita Ramesh
Amgen
Sashi Banappagari
Earli Inc
Sean M Bell
Alector
Zhenyu Gu
Xencor